Apply now: Bristol Myers Squibb’s Golden Ticket—$50K lab credit to LabCentral >

Search

Harvard life sciences incubator says startups raised $30M in first year after launch

Navitor Pharmaceuticals’ Scientific Founder Makes Seminal Discoveries Related to Role of Nutrient Sensors in mTOR Regulation and Activity

Navitor Pharmaceuticals to Develop NV-5138, a Specific Activator of mTORC1 for Treatment-Resistant Depression, Based on Promising Data Presented at Society for Neuroscience 2017

Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Neutrolis, Remora Therapeutics

Read More

Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients’ Lives

Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board

Cocoon Biotech Appoints Dr. Annalisa Jenkins as…
Read More

Tissue Modeling May Cut Clinical Trial Time

Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products

Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral

Affinivax $6.99 million Fundraising. Steven Brugger Released Jan 5 SEC form